

CYCC, ATEC, FSIN, CVVT, OXBT, CERP Are Seasonally Ripe To Go Down In the Next Five Weeks
August 23, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of CYCLACEL PHARMACEUTICALS INC (NASDAQ:CYCC), ALPHATEC HOLDINGS INC (NASDAQ:ATEC), FUSHI COPPERWELD INC (NASDAQ:FSIN), CHINA VALVES TECHNOLOGY INC (NASDAQ:CVVT), OXYGEN BIOTHERAPEUTICS INC (OTC:OXBT), CEREPLAST INC (OTCBB:CERP) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date CYCC CYCLACEL PHARMACEUTICALS INC -11.10% 100.00% (7 of 7) Friday, September 16th 2011 ATEC ALPHATEC HOLDINGS INC -9.52% 100.00% (5 of 5) Thursday, September 29th 2011 FSIN FUSHI COPPERWELD INC -10.61% 66.67% (4 of 6) Wednesday, September 14th 2011 CVVT CHINA VALVES TECHNOLOGY INC -12.34% 100.00% (5 of 5) Monday, September 19th 2011 OXBT OXYGEN BIOTHERAPEUTICS INC -15.59% 90.91% (10 of 11) Monday, October 3rd 2011 CERP CEREPLAST INC -17.66% 100.00% (5 of 5) Monday, October 3rd 2011CYCLACEL PHARMACEUTICALS INC (NASDAQ:CYCC) - Cyclacel Pharmaceuticals, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of mechanism-targeted drugs to treat human cancer and other serious disorders. Its orally-available drugs in clinical development include Sapacitabine (CYC682), an oral nucleoside analogue, which is in phase II studies for the treatment of hematological malignancies, such as acute myeloid leukemia in the elderly, myelodysplastic syndromes, cutaneous T-cell lymphoma, and lung cancer; Seliciclib (CYC202), a CDK (cyclin dependent kinase) inhibitor, which is in phase II studies for the treatment of lung cancer and nasopharyngeal cancer; and CYC116, an Aurora kinase and VEGFR2 inhibitor that is in phase I studies for patients with advanced solid tumors. The company, through its subsidiary, ALIGN Pharmaceuticals, LLC, markets directly Xclair Cream for radiation dermatitis, as well as Numoisyn Liquid and Numoisyn Lozenges for xerostomia in the United States. It focuses on building a diversified biopharmaceutical business focused in hematology, oncology, and other therapeutic areas based on a portfolio of commercial products and a development pipeline of novel drug candidates. The company was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.
ALPHATEC HOLDINGS INC (NASDAQ:ATEC) - Alphatec Holdings, Inc., through its wholly owned subsidiary, Alphatec Spine, Inc., engages in the design, development, manufacture, and marketing of products for the surgical treatment of spine disorders, primarily focused on the aging spine. The companys products include Thoracolumbar fixation systems, which are used to facilitate fusion, the growth of a bony connection between two adjacent vertebrae; Zodiac Degenerative Fixation System that offers various polyaxial pedicle screws and advanced instruments; CORE Lumbar Plating System, a posterior lumbar plating system that provides an alternative to screw and rod constructs; and Zodiac Deformity Fixation System with polyaxial screws, connectors, and instrumentation to enable the surgeon to address patient-specific spinal deformities. It also offers Spinal Spacers to be inserted in the space between vertebrae to provide support in order to restore disc space height, alignment, and the spines weight-bearing function; Allograft Spacers to accelerate the creation of living bone cells and incorporate the allograft into the newly created, living bone; Anterior Cervical Plating to stabilize the vertebrae to facilitate fusion; and Solanas Posterior Cervico/Thoracic Fixation System that provides a solution for posterior cervico/thoracic procedures. In addition, Alphatec Holdings provides adjustable bridges, bone grafting materials, vertebroplasty products, minimally invasive access systems and techniques, vacuum infusion packaging system, and wound barriers. The company serves cervical, thoracolumbar, intervertebral, minimally invasive, vertebral compression fracture, disorders related to poor bone quality, and spinal stenosis markets. It sells its products through independent distributors, direct sales representatives, and sales management employees and executives in the United States, Asia, and Europe. The company was incorporated in 2005 and is headquartered in Carlsbad, California.
FUSHI COPPERWELD INC (NASDAQ:FSIN) - Fushi Copperweld, Inc., through its subsidiaries, develops, designs, manufactures, markets, and distributes bimetallic wire products, principally copper-clad aluminum (CCA) and copper-clad steel (CCS). Its CCA and CCS conductors are used as a substitute for solid copper conductors in applications where specific electrical or physical attributes are necessary. The company markets its products under Copperweld and Fushi brand names. It primarily serves end-user applications in the telecommunication, electrical utility, and transportation markets. The companys CCS products in the utility market are used in grounding applications, power cables, electrified railroad tracks, and tracer wires. Its CCS and CCA wires in transportation market are used in original equipment and aftermarket applications for electrified rail applications, as well as in automobiles, trucks, motorcycles, commercial off road equipment, and trailers. The company sells its products through its direct sales force, as well as through sales agents or distributors primarily in North America, Europe, North Africa, the Middle East, and the Peoples Republic of China. Fushi Copperweld, Inc. is based in Beijing, the Peoples Republic of China.
CHINA VALVES TECHNOLOGY INC (NASDAQ:CVVT) - China Valves Technology, Inc., through its subsidiaries, engages in developing, manufacturing, and selling low, medium, and high-pressure metal valves for customers in the electricity, petroleum, chemical, water, gas, nuclear power station, and metal industries in China. The companys product categories include high pressure and high temperature valves for power station units; valves for long distance petroleum and gas pipelines, and sewage; special valves for chemical lines; and large valves for water supply pipe networks. Its products comprise gate, globe, check, throttle, butterfly, ball, safety, water pressure test, vacuum, and extraction check valves. The company markets its products through regional agents and distributors. China Valves Technology, Inc. has a strategic cooperation frame agreement with Dongfang Electric Corporation for the development of high-end valves. The company was founded in 2007 and is headquartered in Kaifeng City, the People's Republic of China.
OXYGEN BIOTHERAPEUTICS INC (OTC:OXBT) - Oxygen Biotherapeutics, Inc. develops medical and cosmetic products that deliver oxygen to tissues in the body. It develops a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier called Oxycyte that is being formulated for both intravenous and topical delivery for conditions, including but not limited to traumatic brain injury, decompression sickness, cosmetics, and topical wounds. The companys under development product include Vitavent, an oxygen exchange fluid for facilitating the treatment of lung conditions. In addition, it out-licensed its rights to a biosensor implant product that uses an enzyme process for measuring the glucose level in subcutaneous fluid. Further, Oxygen Biotherapeutics offers Dermacyte line of oxygen-rich skin care products that promote the appearance of skin health and other desirable cosmetic benefits; and Wundecyte, a wound-healing gel. The company markets and sells Dermacyte line of products through www.buydermacyte.com; and to dermatologists and medical spas with a combination of in-house sales and exclusive distributors. The company was formerly known as Synthetic Blood International, Inc. and changed its name to Oxygen Biotherapeutics, Inc. in June 2008. Oxygen Biotherapeutics was founded in 1967 and is based in Durham, North Carolina.
CEREPLAST INC (OTCBB:CERP) - Cereplast, Inc. develops and commercializes bio-based resins in the United States. The companys product includes Cereplast Compostables resins, which is substitutes for petroleum-based plastics targeting primarily single-use disposables and packaging applications. It also offers Cereplast Hybrid Resins that replace up to 50% of the petroleum content in conventional plastics with bio-based materials, such as industrial starches sourced from plants for use in a range of markets, including automotive, consumer goods, consumer electronics, medical, packaging, and construction. The companys resins are also used in various conventional converting processes, including injection molding, thermoforming, blow film, blow molding, and extrusion. Its developing product also includes Cereplast Algae Plastics to transform algae into bioplastics. The company was formerly known as Biocorp North America Inc. and changed its name to Cereplast, Inc. in March 2005. Cereplast, Inc. was incorporated in 2001 and is headquartered in El Segundo, California.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641